1
|
Equal contributions of feline immunodeficiency virus and coinfections to morbidity in African lions. Int J Parasitol Parasites Wildl 2021; 16:83-94. [PMID: 34466379 PMCID: PMC8385399 DOI: 10.1016/j.ijppaw.2021.07.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 07/12/2021] [Accepted: 07/12/2021] [Indexed: 11/22/2022]
Abstract
Feline immunodeficiency virus (FIV) is a pathogenic lentivirus related to human and simian immunodeficiency viruses that has been associated with AIDS-like pathologies in domestic and wild cats, as well as in hyenas. Despite known pathologies, progressive immunosuppression and ill health effects driven by these lentiviruses in association with other secondary infections remain understudied in free-ranging species. Here, the role of coinfections by gastrointestinal parasites and tick-borne hemoparasites for FIV disease progression was explored in 195 free-ranging African lions (Panthera leo) living in Kruger National Park (KNP), South Africa. Using statistical methodology, we evaluated the effects of FIV on a range of health indicators to explore how direct and indirect effects of FIV and associated coinfections align to determine lion health outcomes. Findings show direct negative effects of FIV on host immunity and nutritional status, and exacerbation of aggressive behaviors, conditions which may increase exposure/susceptibility to other secondary infections. When taken together, the contribution of coinfecting parasites to morbidity in lions is of similar magnitude as direct effects of FIV infection alone, suggesting that the particular coinfection assemblage may play a role in mediating disease progression within natural lion populations. Immunosuppression by FIV increases richness and abundance of secondary parasites. Infection by gastrointestinal parasites drives severe malnourishment in FIV hosts. Hemoparasite infection contributed to liver pathology and clinical wasting. Contributions of secondary infections to morbidity equal the direct effects of FIV.
Collapse
|
2
|
Gabai G, Mongillo P, Giaretta E, Marinelli L. Do Dehydroepiandrosterone (DHEA) and Its Sulfate (DHEAS) Play a Role in the Stress Response in Domestic Animals? Front Vet Sci 2020; 7:588835. [PMID: 33195624 PMCID: PMC7649144 DOI: 10.3389/fvets.2020.588835] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Accepted: 09/25/2020] [Indexed: 12/16/2022] Open
Abstract
In animal husbandry, stress is often associated with poor health and welfare. Stress occurs when a physiological control system detects a state of real or presumptive threat to the animal's homeostasis or a failure to control a fitness-critical variable. The definition of stress has mostly relied on glucocorticoids measurement, even though glucocorticoids represent one stress-response system, the hypothalamus-pituitary-adrenocortical axis, which is not precise enough as it is also related to metabolic regulation and activated in non-stressful situations (pleasure, excitement, and arousal). The mammal adrenal can synthesize the androgenic steroid dehydroepiandrosterone (DHEA) and its sulfate metabolite (DHEAS), which have been associated to the stress response in several studies performed mostly in humans and laboratory animals. Although the functions of these steroids are not fully understood, available data suggest their antagonistic effects on glucocorticoids and, in humans, their secretion is affected by stress. This review explores the scientific literature on DHEA and DHEAS release in domestic animals in response to stressors of different nature (inflammatory, physical, or social) and duration, and the extra-adrenal contribution to circulating DHEA. Then, the potential use of DHEA in conjunction with cortisol to improve the definition of the stress phenotype in farmed animals is discussed. Although the focus of this review is on farmed animals, examples from other species are reported when available.
Collapse
Affiliation(s)
- Gianfranco Gabai
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy
| | - Paolo Mongillo
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy
| | - Elisa Giaretta
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy
| | - Lieta Marinelli
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy
| |
Collapse
|
4
|
McIlmoil S, Call GB, Barney M, Strickland J, Judd AM. Interleukin-6 inhibits adrenal androgen release from bovine adrenal zona reticularis cells by inhibiting the expression of steroidogenic proteins. Domest Anim Endocrinol 2015. [PMID: 26218834 DOI: 10.1016/j.domaniend.2015.05.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Interleukin-6 (IL-6) is secreted by adrenocortical cells and modifies cortisol secretion. In this study, the effects of IL-6 on adrenal androgen release were investigated. The zona reticularis (ZR) was generally isolated from bovine adrenal glands by dissection. In select experiments, the intact adrenal cortex (ie, all 3 adrenocortical zones) was dissected from the adrenal glands. For androgen release experiments, ZR and intact adrenocortical cubes were dispersed into isolated cells, the cells cultured and exposed to IL-6 and/or adrenocorticotropic hormone (ACTH), and androgen release determined by radioimmunoassay. Basal and ACTH-stimulated androgen release from the ZR was inhibited by IL-6 in a concentration-dependent (10-1000 pg/mL) and time-dependent (4-24 h) manner (P < 0.01 by 1-way analysis of variance and the Bonferroni test). In contrast, IL-6 increased basal and ACTH-stimulated androgen release from mixed adrenocortical cells (P < 0.01). The mechanism of IL-6 inhibition of androgen release was investigated by exposing ZR strips to IL-6 and measuring the expression of the messenger RNA (mRNA) and protein of steroidogenic factors. Basal and ACTH-stimulated expression of the mRNA and protein for steroidogenic acute regulatory protein, cholesterol side chain cleavage enzyme, 3-β-hydroxysteroid dehydrogenase type 2, steroid 17-α-hydroxylase/17,20 lyase/17,20 desmolase, and the nuclear factor steroidogenic factor 1 (SF-1), that stimulates steroidogenesis, were decreased by IL-6 (P < 0.01). In contrast IL-6 increased the mRNA and protein for dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1), a nuclear factor that inhibits steroidogenesis (P < 0.01). In summary, IL-6 decreased androgen release and the expression of steroidogenic factors in the ZR, and this decrease may be mediated in part through increasing DAX-1 and decreasing SF-1.
Collapse
Affiliation(s)
- S McIlmoil
- Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT, 84602, USA; Neuroscience Center, Brigham Young University, Provo, UT, 84602, USA
| | - G B Call
- Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT, 84602, USA; Neuroscience Center, Brigham Young University, Provo, UT, 84602, USA
| | - M Barney
- Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT, 84602, USA; Neuroscience Center, Brigham Young University, Provo, UT, 84602, USA
| | - J Strickland
- Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT, 84602, USA; Neuroscience Center, Brigham Young University, Provo, UT, 84602, USA
| | - A M Judd
- Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT, 84602, USA; Neuroscience Center, Brigham Young University, Provo, UT, 84602, USA.
| |
Collapse
|
5
|
Gomez-Lucia E, Sanjosé L, Crespo O, Reina R, Glaria I, Ballesteros N, Amorena B, Doménech A. Modulation of the long terminal repeat promoter activity of small ruminant lentiviruses by steroids. Vet J 2014; 202:323-8. [PMID: 25168719 DOI: 10.1016/j.tvjl.2014.08.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2013] [Revised: 08/02/2014] [Accepted: 08/03/2014] [Indexed: 10/24/2022]
Abstract
Production and excretion of small ruminant lentiviruses (SRLVs) varies with the stage of the host reproductive cycle, suggesting hormonal involvement in this variation. Stress may also affect viral expression. To determine if hormones affect SRLV transcriptional activity, the expression of green fluorescent protein (GFP) driven by the promoters in the U3-cap region of the long terminal repeats (LTRs) of different strains of SRLV was assessed in cell culture. High concentrations of steroids (progesterone, cortisol and dehydroepiandrosterone) inhibited expression of GFP driven by SRLV promoters. This effect decreased in a dose-dependent manner with decreasing concentrations of steroids. In some strains, physiological concentrations of cortisol or dehydroepiandrosterone (DHEA) induced the expression of GFP above the baseline. There was strain variation in sensitivity to hormones, but this differed for different hormones. The presence of deletions and a 43 base repeat in the U3 region upstream of the TATA box of the LTR made strain EV1 less sensitive to DHEA. However, no clear tendencies or patterns were observed when comparing strains of different genotypes and/or subtypes, or those triggering different forms of disease.
Collapse
Affiliation(s)
- Esperanza Gomez-Lucia
- Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain.
| | - Leticia Sanjosé
- Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), 31192 Mutilva Baja, Spain
| | - Oscar Crespo
- Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Ramsés Reina
- Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), 31192 Mutilva Baja, Spain
| | - Idoia Glaria
- Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), 31192 Mutilva Baja, Spain
| | - Natalia Ballesteros
- Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Beatriz Amorena
- Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), 31192 Mutilva Baja, Spain
| | - Ana Doménech
- Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain
| |
Collapse
|